Format

Send to

Choose Destination
Am J Primatol. 2018 Oct;80(10):e22913. doi: 10.1002/ajp.22913. Epub 2018 Oct 3.

Opportunities and challenges for intranasal oxytocin treatment studies in nonhuman primates.

Author information

1
Department of Psychiatry and Behavioral Sciences, University of California, Davis, California.
2
The UC Davis MIND Institute, University of California, Davis, California.
3
California National Primate Research Center, University of California, Davis, California.
4
Sumitomo Dainippon Pharma Co., Ltd., Osaka, Japan.
5
Departments of Neuroscience, Psychology, and Marketing, University of Pennsylvania, Philadelphia, Pennsylvania.

Abstract

Nonhuman primates provide a human-relevant experimental model system to explore the mechanisms by which oxytocin (OT) regulates social processing and inform its clinical applications. Here, we highlight contributions of the nonhuman primate model to our understanding of OT treatment and address unique challenges in administering OT to awake behaving primates. Prior preclinical research utilizing macaque monkeys has demonstrated that OT can modulate perception of other individuals and their expressions, attention to others, imitation, vigilance to social threats, and prosocial decisions. We further describe ongoing efforts to develop an OT delivery system for use in experimentally naïve juvenile macaque monkeys compatible with naturalistic social behavior outcomes. Finally, we discuss future directions to further develop the rhesus monkey as a preclinical test bed to evaluate the effects of OT exposure and advance efforts to translate basic science OT research into safe and effective OT therapies.

KEYWORDS:

delivery; oxytocin; rhesus

PMID:
30281820
DOI:
10.1002/ajp.22913

Supplemental Content

Full text links

Icon for Wiley
Loading ...
Support Center